Pfizer on Wednesday said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to commercial sales after government stocks run out, more than double what the government currently pays for it.
<p>WASHINGTON — Pfizer on Wednesday said it will set the U.S.
, will remain available for free to patients there until the end of the year, Pfizer said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Pfizer to price COVID treatment Paxlovid at $1,390 per coursePfizer on Wednesday (PFE.N) said it will set the U.S. price for its COVID-19 antiviral treatment Paxlovid at nearly $1,400 per five-day course when it moves to commercial sales after government stocks run out.
Read more »
Pfizer to price Covid drug Paxlovid at $1,390 per coursePaxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treatments slumps nationwide.
Read more »
Pfizer to price Covid drug Paxlovid at $1,390 per coursePaxlovid will transition to the private market in November, which comes as demand for Covid vaccines and treatments slumps nationwide.
Read more »
Pfizer more than doubles price of lifesaving COVID-19 medication PaxlovidThe price of the lifesaving COVID-19 antiviral medication Paxlovid will more than double as the United States transitions out of the emergency phase of the pandemic.
Read more »
Pfizer Prices Covid Drug Paxlovid at $1,400 for a Five-Day CourseDrugmaker is expected to offer steep discounts to ensure wide access
Read more »
Pfizer Will Charge $1,390 For 1 Course Of COVID Drug Paxlovid On Commercial MarketNick Visser is a senior reporter on HuffPost’s breaking news team, covering the environment, U.S. politics and world news. Originally based in New York, he now lives in Sydney.
Read more »